ETS‐targeted therapy: can it substitute for MEK inhibitors?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ETS‐targeted therapy: can it substitute for MEK inhibitors?

Published:2017-05-02 Issue:1 Volume:6 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Tetsu Osamu¹²^ORCID,McCormick Frank²

Affiliation:

1. Department of Otolaryngology‐Head and Neck SurgerySchool of MedicineUniversity of CaliforniaSan Francisco94143San FranciscoCAUSA

2. UCSF Helen Diller Family Comprehensive Cancer CenterSchool of MedicineUniversity of CaliforniaSan Francisco94143San FranciscoCAUSA

Funder

National Cancer Institute

The Joan and Irwin Jacobs Fund of the Jewish Community Foundation

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1186/s40169-017-0147-4

Reference110 articles.

1. Cancer Targets in the Ras Pathway

2. Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options

3. The clinical development of MEK inhibitors

4. MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road

5. Expression of urokinase plasminogen activator and receptor in conjunction with the ets family and AP-1 complex transcription factors in high grade prostate cancers

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A data-driven multilayer approach for the identification of potential therapeutic targets in non-alcoholic steatohepatitis;Physica A: Statistical Mechanics and its Applications;2023-08

2. ERK/MAPK Signalling Pathway Regulates MMP2 Through ETS1 in Renal Clear Cell Carcinoma;Current Molecular Medicine;2023-05-29

3. ETS transcription factors: Multifaceted players from cancer progression to tumor immunity;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-05

4. The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia;Cellular and Molecular Life Sciences;2022-09-16

5. Ets1 mediates sorafenib resistance by regulating mitochondrial ROS pathway in hepatocellular carcinoma;Cell Death & Disease;2022-07-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3